(Q28592322)

Fibroblast growth factor receptor 3

GOA release 2020-03-11

1 reference

Journal of Biological Chemistry

GOA release 2020-03-11

author name string

Monica Kong

series ordinal

1

1 reference

31 January 2017

Ching S. Wang

series ordinal

2

1 reference

31 January 2017

Daniel J. Donoghue

series ordinal

3

1 reference

31 January 2017

language of work or name

English

0 references

publication date

3 May 2002

1 reference

31 January 2017

1 reference

31 January 2017

277

1 reference

31 January 2017

15962–15970

1 reference

31 January 2017

18

1 reference

31 January 2017

The ins and outs of fibroblast growth factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Structural and functional specificity of FGF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

FGFR activation in skeletal disorders: too much of a good thing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Fibroblast growth factor receptor 3 is a negative regulator of bone growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Signalling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

SHP2 associates directly with tyrosine phosphorylated p90 (SNT) protein in FGF-stimulated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNT adapter proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

PSM, an insulin-dependent, pro-rich, PH, SH2 domain containing partner of the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Platelet-derived growth factor (PDGF) stimulates the association of SH2-Bbeta with PDGF receptor and phosphorylation of SH2-Bbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

The yeast tribrid system--genetic detection of trans-phosphorylated ITAM-SH2-interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Identification and characterization of novel substrates of Trk receptors in developing neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Insulin-like growth factor-I receptor and insulin receptor association with a Src homology-2 domain-containing putative adapter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

PSM, a mediator of PDGF-BB-, IGF-I-, and insulin-stimulated mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Identification of the cytoplasmic regions of fibroblast growth factor (FGF) receptor 1 which play important roles in induction of neurite outgrowth in PC12 cells by FGF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

A functional DNA binding domain is required for growth hormone-induced nuclear accumulation of Stat5B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Mammalian Ras interacts directly with the serine/threonine kinase Raf

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Ras-Raf interaction: two-hybrid analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

High-efficiency transformation of mammalian cells by plasmid DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

STAT-signalling through the cytoplasmic compartment: consideration of a new paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

STATs and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Fibroblast growth factor receptors: lessons from the genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

RTK mutations and human syndromeswhen good receptors turn bad.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

SH2 and PTB domain interactions in tyrosine kinase signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200

SH2-B is required for nerve growth factor-induced neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102777200